The Leukemia Lymphoma Society S Therapy Acceleration

The Leukemia Lymphoma Society S Therapy Acceleration Program vs Marc S Lipschultz

The Leukemia Lymphoma Society S Therapy Acceleration Program is a venture capital based in New York, New York, United States. Marc S Lipschultz is a private equity based in New York across 70 portfolio companies. Sector focus diverges: The Leukemia Lymphoma Society S Therapy Acceleration Program concentrates on generalist deals and Marc S Lipschultz on Fintech and Proptech.

• Investor type: The Leukemia Lymphoma Society S Therapy Acceleration Program — Venture Capital; Marc S Lipschultz — Private Equity
• Headquarters: The Leukemia Lymphoma Society S Therapy Acceleration Program — New York, New York, United States; Marc S Lipschultz — New York
• Portfolio companies: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Marc S Lipschultz — 70
• Sectors: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Marc S Lipschultz — Fintech, Proptech

• The Leukemia & Lymphoma Society’s Therapy Acceleration Program — Venture Capital · New York, New York, United States · The Leukemia Lymphoma Society S Therapy Acceleration Program portfolio
• Marc S. Lipschultz — Private Equity · New York · 70 tracked deals · Marc S Lipschultz portfolio

Similar investors

• Steven Leischner
• Lexington Partners GP Holdings X, L.L.C.
• Timothy Huang
• Thomas Teles
• iCapital Strategies LLC
• Tom Newby
• Victor L. Wu
• Thomas S. Giannetti
• Governors Lane Fund General Partner LLC
• Harsha Marti

Investors like The Leukemia Lymphoma Society S Therapy Acceleration Program · Investors like Marc S Lipschultz · The Leukemia Lymphoma Society S Therapy Acceleration Program co-investors · Full investor directory